All News

As with many other areas in health care, some patients may face barriers when it comes to genetic services for breast cancer.

Researchers are using artificial intelligence to diagnose sarcopenia in patients with head and neck cancer.

After being diagnosed with cancer, I set intentions — both spiritual and practical — that helped guide me through the experience.

I had acute myeloid leukemia in 2016 and tackled it with chemo. I had a recurrence in 2020 and tackled it with chemo and a bone marrow transplant.

Men with prostate cancer who participated in group-based resistance and aerobic exercise regimens had improved sexual function compared with those who underwent usual care.

From Eric Braeden announces that he is cancer free to Tom Jones dying from cancer, this is what’s happening in the oncology space this week.

An expert discusses the impact on patients and families lacking equal access to counseling and testing.

Researchers have found that interventions can make breast cancer survivors nearly 1.5 times more likely to continue with important post-surgical hormonal therapy.

Patients with blood cancers who had limited social support tended to have poorer survival and a higher likeliness to be hospitalized, recent research showed.

Over the years, I have found social media to be a powerful tool for connecting people with Lynch syndrome.

Although the pandemic prevented Branwyn Lee's family from being with her during cancer treatment, she never felt alone on her journey.

The Food and Drug Administration granted a priority review to Tibsovo for the treatment of patients with IDH1-mutant relapsed or refractory myelodysplastic syndrome.

With multiple therapies available for patients with myeloma, there are some considerations that patients should discuss with their clinicians before choosing which one is right for them, an expert said.

Recent results highlight that men with the disease have not lived as long as female patients have during the past three decades.

The day before I was diagnosed with prostate cancer, I didn’t pay enough attention to my brother-in-law’s arduous journey with Parkinson’s disease.

Patients with HER2-positive metastatic breast cancer may receive sufficient first-line treatment with Perjeta plus Herceptin without chemotherapy.

Geoff Grubbs, who was diagnosed with chronic lymphocytic leukemia in 2009, has undergone five lines of treatment and participated in two clinical trials.

The members of my lung cancer support group recently came up with some responses for when people ask us, "So you have lung cancer — did you smoke?"

PARP inhibitors, primarily used to treat BRCA-mutated disease, may have efficacy potential in triple negative breast cancer.

A year ago, I attended a cancer camp called Camp Make-a-Dream, and I found a specific calling: creativity in jewelry.

Social isolation has become prominent among young cancer survivors, though social connectedness may be beneficial to wellbeing, a recent study showed.

The Hepzato Kit is a direct-to-liver therapy for patients with uveal melanoma with hepatic metastases.

The Food and Drug Administration granted accelerated approval for Elrexfio for the treatment of patients with relapsed or refractory multiple myeloma who previously received at least four lines of therapy.

The countdown to my CT scan has begun.

Certain patients with penile squamous cell carcinoma responded to therapy with an immune checkpoint inhibitor, according to recent research.

Family history of breast and other cancers can mean some people are more likely to develop the disease at a younger age. But advances in testing may improve prevention and survival rates.

Wearable fitness devices can offer valuable insights for patients with cancer and the doctors treating them.

After a certain amount of time in the day, bras become devilish and must be removed immediately!

Using inter-arterial chemotherapy compared to intravenous chemotherapy may significantly improve globe salvage rates in children with advanced unilateral retinoblastoma.

Akeega, the first dual action tablet with a PARP inhibitor and abiraterone acetate, was approved for the treatment of patients with suspected or confirmed BRCA-positive metastatic castration-resistant prostate cancer.